November 26, 2020

Renal Cell Carcinoma Conference

Renal Cell Carcinoma:

————————————————————————————————————————————————————————————-

Current and Emerging Standards in Systemic Therapy

January 31st, 2021

7:30 am -10:15 am PST

Held Virtually on Zoom


Overview

This continuing medical education (CME) activity (live webinar and enduring materials) Renal Cell Carcinoma: Current and Emerging Standards in Systemic Therapy, is intended to improve the care of kidney cancer patients by educating oncologists, nurses, pharmacists, and other healthcare providers about the latest developments in the field. The Renal Cell Carcinoma: Current and Emerging Standards in Systemic Therapy brings together renowned experts in the field. They will share patient case scenarios commonly encountered in clinical practice and will provide learners practical methods to optimize therapy.

Emerging data across the spectrum of kidney cancer management will be reviewed and discussed, from early stage to metastatic disease. The panel of experts will also discuss how they are applying this information to their practices right now, as well as potential future implications.

Target Audience

  • Oncologists
  • Residents/Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses

Educational Objectives

At the conclusion of the activity, participants will be able to:

  1. Describe the pathogenesis, and common molecular abnormalities noted in Renal Cell
    Carcinoma (RCC).
  2. Discuss the management of localized RCC with emphasis on the role of adjuvant systemic
    therapy.
  3. Identify optimal first-line management of metastatic or advanced RCC
  4. Review the second or later lines of treatment of advanced/metastatic RCC with emphasis on molecular markers.


CME Credit Statement

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 2.AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 2.0 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.0 Contact Hours.

ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Course Highlights

  • An innovative and integrated learning environment.
  • Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
  • Livestream delivery method allows ample opportunities to network with colleagues and interacts with faculties; enduring materials allow learners opportunities to learn at their convenience.
  • Program topics can immediately be applied to clinical practice.

Faculty

Dr. Toni K. Choueiri

Lank Center for Genitourinary Oncology

Dr. Arpita Desai

UC San Francisco

Dr. Shuchi Gulati

University of Cincinnati

Dr. Alice Fan

Stanford

Moderator

Dr. Siddhartha Yadav

Mayo Cancer Clinic

Independence & Integrity of this educational Activity

Disclosure of off-label product

This educational activity may or may not contain discussions of investigational, unapproved, or off-label products. Participants should consult prescribing information for products discussed during these meetings. Faculties will disclose at the time of presentation if any off-label product being discussed.


Disclosure of Conflict of Interest

The Binaytara Foundation collects disclosure information from all faculty and organizing committee members involved in planning, implementation, and evaluation of our continuing medical education activities. All conflict will be identified and mitigated for everyone in control of the contents of this activity before their participation in this educational activity.

No member of the activity planning committee has any relevant financial relationship with an ACCME defined ineligible entity. 

Faculty disclosure of relevant financial relationship will be provided to participants during the meeting. Participants can also request a copy of the faculty disclosure ahead of time before their participation in this Continuing Medical Education activity. Please contact [email protected] to request the disclosures.